NCT03371329View on ClinicalTrials.gov

Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage

PHASE1CompletedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

October 9, 2020

Study Completion Date

October 9, 2020

Conditions

Hemorrhagic StrokeIntracerebral Hemorrhage

Interventions

BIOLOGICAL

MSC

bone marrow derived cultured MSC (mesenchymal stem cell)

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER